144 related articles for article (PubMed ID: 35028339)
1. Sex-specific differences in direct osteoclastic
Deosthale P; Hong JM; Essex AL; Rodriguez W; Tariq D; Sidhu H; Marcial A; Bruzzaniti A; Plotkin LI
Bone Rep; 2022 Jun; 16():101164. PubMed ID: 35028339
[TBL] [Abstract][Full Text] [Related]
2. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.
Okamoto M; Murai J; Imai Y; Ikegami D; Kamiya N; Kato S; Mishina Y; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2011 Oct; 26(10):2511-22. PubMed ID: 21786321
[TBL] [Abstract][Full Text] [Related]
3. Aryl hydrocarbon receptor catabolic activity in bone metabolism is osteoclast dependent in vivo.
Yu TY; Kondo T; Matsumoto T; Fujii-Kuriyama Y; Imai Y
Biochem Biophys Res Commun; 2014 Jul; 450(1):416-22. PubMed ID: 24938130
[TBL] [Abstract][Full Text] [Related]
4. miR21 deletion in osteocytes has direct and indirect effects on skeletal muscle in a sex-dimorphic manner in mice.
Essex AL; Deosthale P; Huot JR; Davis HM; Momeni N; Bonetto A; Plotkin LI
Biol Sex Differ; 2022 Oct; 13(1):56. PubMed ID: 36183096
[TBL] [Abstract][Full Text] [Related]
5. Age- and sex-dependent role of osteocytic pannexin1 on bone and muscle mass and strength.
Aguilar-Perez A; Pacheco-Costa R; Atkinson EG; Deosthale P; Davis HM; Essex AL; Dilley JE; Gomez L; Rupert JE; Zimmers TA; Thompson RJ; Allen MR; Plotkin LI
Sci Rep; 2019 Sep; 9(1):13903. PubMed ID: 31554905
[TBL] [Abstract][Full Text] [Related]
6. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
7.
Moriishi T; Kawai Y; Fukuyama R; Matsuo Y; He YW; Akiyama H; Asahina I; Komori T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139148
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity.
Loveridge CJ; van 't Hof RJ; Charlesworth G; King A; Tan EH; Rose L; Daroszewska A; Prior A; Ahmad I; Welsh M; Mui EJ; Ford C; Salji M; Sansom O; Blyth K; Leung HY
Sci Rep; 2017 Oct; 7(1):13241. PubMed ID: 29038439
[TBL] [Abstract][Full Text] [Related]
9. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
10. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic or Osteoclast-Specific Deletion of Syk Leads to Increased Bone Mass in Experimental Mice.
Csete D; Simon E; Alatshan A; Aradi P; Dobó-Nagy C; Jakus Z; Benkő S; Győri DS; Mócsai A
Front Immunol; 2019; 10():937. PubMed ID: 31134061
[TBL] [Abstract][Full Text] [Related]
12. Runt-related transcription factor-2 (Runx2) is required for bone matrix protein gene expression in committed osteoblasts in mice.
Qin X; Jiang Q; Komori H; Sakane C; Fukuyama R; Matsuo Y; Ito K; Miyazaki T; Komori T
J Bone Miner Res; 2021 Oct; 36(10):2081-2095. PubMed ID: 34101902
[TBL] [Abstract][Full Text] [Related]
13. GATA4 represses RANKL in osteoblasts via multiple long-range enhancers to regulate osteoclast differentiation.
Khalid AB; Slayden AV; Kumpati J; Perry CD; Berryhill SB; Crawford JA; Fatima I; Morselli M; Pellegrini M; Miranda-Carboni GA; Krum SA
Bone; 2018 Nov; 116():78-86. PubMed ID: 30031905
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of Irf8 by Lyz2-cre/loxP accelerates osteoclast differentiation in vitro.
Saito E; Suzuki D; Kurotaki D; Mochizuki A; Manome Y; Suzawa T; Toyoshima Y; Ichikawa T; Funatsu T; Inoue T; Takami M; Tamura T; Inagaki K; Kamijo R
Cytotechnology; 2017 Jun; 69(3):443-450. PubMed ID: 27502007
[TBL] [Abstract][Full Text] [Related]
15. Runx1 Regulates Myeloid Precursor Differentiation Into Osteoclasts Without Affecting Differentiation Into Antigen Presenting or Phagocytic Cells in Both Males and Females.
Paglia DN; Yang X; Kalinowski J; Jastrzebski S; Drissi H; Lorenzo J
Endocrinology; 2016 Aug; 157(8):3058-69. PubMed ID: 27267711
[TBL] [Abstract][Full Text] [Related]
16. Negative Regulation of Osteoclast Commitment by Intracellular Protein Phosphatase Magnesium-Dependent 1A.
Kwon OC; Choi B; Lee EJ; Park JE; Lee EJ; Kim EY; Kim SM; Shin MK; Kim TH; Hong S; Lee CK; Yoo B; Robinson WH; Kim YG; Chang EJ
Arthritis Rheumatol; 2020 May; 72(5):750-760. PubMed ID: 31762216
[TBL] [Abstract][Full Text] [Related]
17. High bone mass in mice lacking Cx37 because of defective osteoclast differentiation.
Pacheco-Costa R; Hassan I; Reginato RD; Davis HM; Bruzzaniti A; Allen MR; Plotkin LI
J Biol Chem; 2014 Mar; 289(12):8508-20. PubMed ID: 24509854
[TBL] [Abstract][Full Text] [Related]
18. Myeloid Pannexin-1 mediates acute leukocyte infiltration and leads to worse outcomes after brain trauma.
Seo JH; Dalal MS; Calderon F; Contreras JE
J Neuroinflammation; 2020 Aug; 17(1):245. PubMed ID: 32819386
[TBL] [Abstract][Full Text] [Related]
19. Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.
Yang M; Trettel LB; Adams DJ; Harrison JR; Canalis E; Kream BE
Bone; 2010 Sep; 47(3):573-82. PubMed ID: 20541046
[TBL] [Abstract][Full Text] [Related]
20. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
Dela Cruz A; Grynpas MD; Mitchell J
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
